In pancreatic adenocarcinoma cells, the combination treatment of Everolimus, an antitumor agent that inhibits the mTOR pathway, with Genipin synergistically inhibited cancer cell proliferation by increasing the nuclear translocation of GAPDH [147]. The gene discussed is GAPDH; the disease is pancreatic adenocarcinoma.